D000981Chemicals & DrugsD27.505.954.122.250.10014330.978427Antiprotozoal Agentsplugins:TwitterTwitterprns:emailEncryptedemail addressprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:pluginSearchableDataProfilesRNS Plugin Searchable Dataprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation Resourcevivo:linkAnchorTextlink anchor textPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forURLLinkvivo:webpagewebpagerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson28384261Berger BA, Cossio A, Saravia NG, Castro MDM, Prada S, Bartlett AH, Pho MTPLoS neglected tropical diseasesCost-effectiveness of meglumine antimoniate versus miltefosine caregiver DOT for the treatment of pediatric cutaneous leishmaniasis. PLoS Negl Trop Dis. 2017 04; 11(4):e0005459.PLoS Negl Trop Dis2017-04-06T00:00:002017Cost-effectiveness of meglumine antimoniate versus miltefosine caregiver DOT for the treatment of pediatric cutaneous leishmaniasis.2.554030.019725814research area of0.8336070.046865425subject area forPritzker Institute for Molecular EngineeringMontidaVeeravigromMontida Veeravigrom41.7886000000000087.598699999999993969Veeravigrom, MontidaAssistant ProfessorOphthalmology and Visual Science22354304Fomovska A, Huang Q, El Bissati K, Mui EJ, Witola WH, Cheng G, Zhou Y, Sommerville C, Roberts CW, Bettis S, Prigge ST, Afanador GA, Hickman MR, Lee PJ, Leed SE, Auschwitz JM, Pieroni M, Stec J, Muench SP, Rice DW, Kozikowski AP, McLeod RAntimicrobial agents and chemotherapyNovel N-benzoyl-2-hydroxybenzamide disrupts unique parasite secretory pathway. Antimicrob Agents Chemother. 2012 May; 56(5):2666-82.Antimicrob Agents Chemother2012-02-21T00:00:002012Novel N-benzoyl-2-hydroxybenzamide disrupts unique parasite secretory pathway.http://www.researchgate.net/profile/John_Fung2/stats/Research Gatehttps://ophthalmology.uchicago.edu/The University of Chicago Department of Ophthalmologyhttps://publons.com/author/1183306/john-fung#profilePublonshttps://www.healthtap.com/#experts/11185863/aboutHealth Taphttps://orcid.org/0000-0002-3038-0441ORCIDhttps://ophthalmology.uchicago.edu/Department of OphthalmologyUChicagoOVS UChicagoOVS SurgeryUniversity of ChicagoRimaMcLeodxW9qB6QaHczbgn4qdUXm+mb7+MTz7LFLRima McLeod41.78927490000000-87.601250000000002187McLeod, RimaProfessor33940589Kaushik D, Granato JT, Macedo GC, Dib PRB, Piplani S, Fung J, da Silva AD, Coimbra ES, Petrovsky N, Salunke DBThe Journal of pharmacy and pharmacologyToll-like receptor-7/8 agonist kill Leishmania amazonensis by acting as pro-oxidant and pro-inflammatory agent. J Pharm Pharmacol. 2021 Aug 12; 73(9):1180-1190.J Pharm Pharmacol2021-08-12T00:00:002021Toll-like receptor-7/8 agonist kill Leishmania amazonensis by acting as pro-oxidant and pro-inflammatory agent.true1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professortrue1Research Assistant ProfessorResearch Assistant Professortrue1ProfessorProfessor24295325Afanador GA, Muench SP, McPhillie M, Fomovska A, Schön A, Zhou Y, Cheng G, Stec J, Freundlich JS, Shieh HM, Anderson JW, Jacobus DP, Fidock DA, Kozikowski AP, Fishwick CW, Rice DW, Freire E, McLeod R, Prigge STBiochemistryDiscrimination of potent inhibitors of Toxoplasma gondii enoyl-acyl carrier protein reductase by a thermal shift assay. Biochemistry. 2013 Dec 23; 52(51):9155-66.Biochemistry2013-12-13T00:00:002013Discrimination of potent inhibitors of Toxoplasma gondii enoyl-acyl carrier protein reductase by a thermal shift assay.Pediatrics-NeurologyAsimFarooqAsim Farooq0.000000000000000.000000000000003355Farooq, AsimAssociate ProfessorJohnFungJohn Fung0.000000000000000.000000000000003383Fung, JohnProfessorKamalEl BissatiKamal El Bissati0.000000000000000.000000000000002795El Bissati, KamalResearch Assistant Professor23776166Stec J, Fomovska A, Afanador GA, Muench SP, Zhou Y, Lai BS, El Bissati K, Hickman MR, Lee PJ, Leed SE, Auschwitz JM, Sommervile C, Woods S, Roberts CW, Rice D, Prigge ST, McLeod R, Kozikowski APChemMedChemModification of triclosan scaffold in search of improved inhibitors for enoyl-acyl carrier protein (ACP) reductase in Toxoplasma gondii. ChemMedChem. 2013 Jul; 8(7):1138-60.ChemMedChem2013-06-14T00:00:002013Modification of triclosan scaffold in search of improved inhibitors for enoyl-acyl carrier protein (ACP) reductase in Toxoplasma gondii.